Evelo Biosciences to Present at Upcoming Investor Conferences in June
Date:
Time:
Location:
BMO Prescriptions for
Date:
Time:
Location:
A live audio webcast of both presentations will be available on the Investors section of the Evelo website at http://ir.evelobio.com/news-events. Replays of the webcasts will be available for approximately 30 days following each presentation.
About
Evelo currently has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer, for which ten clinical readouts are expected during 2019 and 2020. Evelo is also advancing additional oral biologics through preclinical development in other disease areas.
For more information, please visit www.evelobio.com.
Contact
617-577-0300
stefan@evelobio.com
Source: Evelo Biosciences, Inc.